Clinical Trial

A new migraine medication called ubrogepant recently passed a large scale phase 3 clinical trial. This medication may be able to help treat patients that cannot tolerate or do not respond to the most common types of migraine medication.

by Isabella Grabski figures by Jovana Andrejevic Clinical trials are critical to study the safety and effectiveness of new drugs, but they are no small endeavor. The cost of a clinical trial can range anywhere from $7 million to over $50 million, and…

Researchers from Kyoto University in Japan started a clinical trial this month to treat Parkinson’s disease with reprogrammed stem cells. This follows the successful restoration of brain cell function in monkeys using these stem cells reported last…

In 2018, approximately 5.7 million Americans are living with Alzheimer’s dementia, a number that is expected to double within the next 30 years. Alzheimer’s disease causes memory loss, mood changes, and eventually difficulty speaking, swallowing, and…

Two bears and a mountain lion suffered extreme burns to their paws during the California wildfires in December. Treating the animals with the traditional procedures was proving difficult, so vets turned to an experimental treatment: fish skin bandages.…

by Giulia Notarangelo figures by Abagail Burrus A drug that might significantly reduce the risk of heart attack and lung cancer is being hailed by researchers as the biggest breakthrough in the treatment of cardiovascular disease since the introduction…

What is the difference between a normal cell and a cancer cell? The answer lies in their DNA. Cancer results from the accumulation of genetic mutations, which trigger uncontrolled cell growth. Cancer’s mutated DNA can reveal its presence early on in…

High-resolution microscope image of a lymphocyte, the part of the immune system that interacts with Keytruda [‘T Lymphocyte’ from NIAID] Results from a small clinical trial comprising 86 cancer patients have prompted scientists to rethink how…

Repatha’s clinical trial involved over 27,000 patients and cost over $1 billion. [‘The City’ from Herry Lawford] We just learned a lot more about a drug called Repatha, one of the newest weapons in the war against heart disease. …

Image of a T cell, a critical part of the human immune system, taken with a high-resolution electron microscope. [‘Healthy Human T Cell’ from NIAID]Bringing a new medical therapy to market is rarely a straightforward task, as a biotech…